Publications by authors named "Chandana B Herath"

33Publications

ACE2: from protection of liver disease to propagation of COVID-19.

Clin Sci (Lond) 2020 12;134(23):3137-3158

South Western Sydney Clinical School, University of New South Wales, Ingham Institute for Applied Medical Research, Sydney, Australia.

View Article and Find Full Text PDF
December 2020

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.

World J Gastroenterol 2020 Oct;26(40):6111-6140

Department of Medicine, Melbourne Medical School, The University of Melbourne, Heidelberg, VIC 3084, Australia.

View Article and Find Full Text PDF
October 2020

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.

Int J Mol Sci 2019 Oct 11;20(20). Epub 2019 Oct 11.

Department of Medicine, The University of Melbourne, Melbourne 3084, Australia.

View Article and Find Full Text PDF
October 2019

Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats.

Front Physiol 2019 20;10:1169. Epub 2019 Sep 20.

Department of Medicine, The University of Melbourne, Austin Health, Melbourne, VIC, Australia.

View Article and Find Full Text PDF
September 2019

Current therapies and novel approaches for biliary diseases.

World J Gastrointest Pathophysiol 2019 Jan;10(1):1-10

Department of Medicine, The University of Melbourne, Melbourne, VIC 3084, Australia.

View Article and Find Full Text PDF
January 2019

The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.

Sci Rep 2018 07 5;8(1):10175. Epub 2018 Jul 5.

Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

View Article and Find Full Text PDF
July 2018

The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders.

Curr Gene Ther 2017 ;17(1):4-16

Department of Medicine, the University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

View Article and Find Full Text PDF
April 2018

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.

World J Gastroenterol 2016 Sep;22(35):8026-40

Christopher Leung, Chandana B Herath, Zhiyuan Jia, Sof Andrikopoulos, Peter W Angus, Department of Medicine, the University of Melbourne, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia.

View Article and Find Full Text PDF
September 2016

ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.

Mol Ther 2015 Sep 25;23(9):1434-43. Epub 2015 May 25.

Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

View Article and Find Full Text PDF
September 2015

Dietary glycotoxins exacerbate progression of experimental fatty liver disease.

J Hepatol 2014 Apr 6;60(4):832-8. Epub 2013 Dec 6.

Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia; Department of Gastroenterology and Hepatology, Austin Health, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
April 2014

Profiles of perfluoroalkyl substances in the liver and serum of patients with liver cancer and cirrhosis in Australia.

Ecotoxicol Environ Saf 2013 Oct 9;96:139-46. Epub 2013 Jul 9.

Pathology and Pathophysiology Research Division, National Institute of Animal Health, National Agriculture and Food Research Organization, Kannondai 3-1-5, Tsukuba, Ibaraki 305-0856, Japan.

View Article and Find Full Text PDF
October 2013

Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

Gastroenterology 2013 Oct 22;145(4):874-884.e5. Epub 2013 Jun 22.

Department of Medicine, The University of Melbourne, Heidelberg Repatriation Hospital, Heidelberg, Melbourne, Victoria, Australia; Austin Health, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
October 2013

Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

World J Gastrointest Pathophysiol 2013 Feb;4(1):1-11

Chandana B Herath, Josephine A Grace, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Australia.

View Article and Find Full Text PDF
February 2013

Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.

Am J Physiol Gastrointest Liver Physiol 2013 Jan 18;304(1):G99-108. Epub 2012 Oct 18.

Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, Victoria 3084, Victoria, Australia.

View Article and Find Full Text PDF
January 2013

Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.

Clin Sci (Lond) 2012 Aug;123(4):225-39

Department of Medicine, The University of Melbourne, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF
August 2012

Transforming growth factor beta family expression at the bovine feto-maternal interface.

Reprod Biol Endocrinol 2010 Oct 15;8:120. Epub 2010 Oct 15.

Laboratory of Veterinary Physiology, Department of Veterinary Medicine, Iwate University, Morioka, 020-8550 Iwate, Japan.

View Article and Find Full Text PDF
October 2010

Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.

BMC Cancer 2010 Apr 10;10:134. Epub 2010 Apr 10.

Department of Surgery, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.

View Article and Find Full Text PDF
April 2010